Patents by Inventor Patrick Page

Patrick Page has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8481562
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: July 9, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8455485
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: June 4, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8455486
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: June 4, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Piperazine-2-carboxamide derivatives
    Patent number: 8404690
    Abstract: The present invention is related to piperazine-2-carboxamide derivatives of formula (I) for the treatment and/or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery. Wherein A, X, Y, R1 and R2 are as defined in the description.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: March 26, 2013
    Assignee: Merck Serono SA
    Inventors: Patrick Page, Catherine Jorand-Lebrun, Russell J. Thomas, Matthias Schwarz
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8389518
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: March 20, 2008
    Date of Patent: March 5, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
  • Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
    Publication number: 20120316380
    Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: February 17, 2011
    Publication date: December 13, 2012
    Applicant: GENKYOTEX SA
    Inventors: Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
  • Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
    Publication number: 20120316163
    Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: February 17, 2011
    Publication date: December 13, 2012
    Applicant: GENKYOTEX SA
    Inventors: Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
  • Tetrahydroindole derivatives as NADPH oxidase inhibitors
    Patent number: 8288432
    Abstract: The present invention is related to tetrahydroindole derivatives of Formula (I), pharmaceutical composition thereof, methods of preparation thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: October 16, 2012
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
  • Tricyclic spiro derivatives as CRTH2 modulators
    Patent number: 8236963
    Abstract: The present invention is related to the use of spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of spiro derivatives for the modulation of CRTH2 activity.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: August 7, 2012
    Assignee: Merck Serono SA
    Inventors: Matthias Schwarz, Eric Sebille, Christophe Cleva, Cedric Merlot, Dennis Church, Patrick Page, Jacqueline A. Macritchie, John Frederick Atherall, Stefano Crosignani, Doris Pupowicz
  • PYRAZOLINE DIONE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20120172352
    Abstract: The present invention is related to pyrazoline dione derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: September 27, 2010
    Publication date: July 5, 2012
    Applicant: GENKYOTEX SA
    Inventors: Patrick Page, Francesca Gaggini, Benoît Laleu
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20110269757
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: September 22, 2009
    Publication date: November 3, 2011
    Applicant: GENKYOTEX SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20110178082
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: September 22, 2009
    Publication date: July 21, 2011
    Applicant: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Opthalmic Lens Capsule Support
    Publication number: 20110178527
    Abstract: A lens support system for use during extracapsular cataract surgery. The lens support system may be used to support a lens or lens fragment in the event of a posterior capsule tear or zonular dialysis. The lens support system comprises a cannula in which a piston attached to a lens support is slidably disposed. By means of the piston, the lens support is movable between collapsed and expanded configurations.
    Type: Application
    Filed: July 24, 2009
    Publication date: July 21, 2011
    Inventor: Timothy Patrick Page
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20110178081
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: September 22, 2009
    Publication date: July 21, 2011
    Applicant: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20110172266
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: September 22, 2009
    Publication date: July 14, 2011
    Applicant: GENKYOTEX SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyridinyl acetonitriles
    Patent number: 7855212
    Abstract: The present invention is related to pyridinyl acetonitriles as well as to pharmaceutical formulations containing such pyridinyl acetonitriles. Said pyridinyl acetonitriles are modulators of the protein kinase signalling pathways, particularly the one involving Glycogen Kinase Synthase 3 or JNK. The present invention is furthermore related to methods of preparing pyridinyl acetonitriles. X is a substituted or unsubstituted pyridinyl. G is an unsubstituted or substituted pyrimidinyl or triazinyl.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: December 21, 2010
    Assignee: Merck Serono SA
    Inventors: Matthias Schwarz, Pascale Gaillard, Jean-Pierre Gotteland, Russell J. Thomas, Patrick Page
  • TETRAHYDROINDOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20100120749
    Abstract: The present invention is related to tetrahydroindole derivatives of Formula (I), pharmaceutical composition thereof, methods of preparation thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: March 28, 2008
    Publication date: May 13, 2010
    Applicant: GENKYO TEX SA
    Inventors: Patrick Page, Mike Orchard, Laeticia Fioraso-Cartier, Bianca Mottironi
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20100048560
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: March 20, 2008
    Publication date: February 25, 2010
    Applicant: GENKYOTEX SA
    Inventors: Patrick Page, Mike Orchard, Leiticia Fioraso, Bianca Mottiromi
  • Tricyclic spiro derivatives as CRTH2 modulators
    Publication number: 20090318486
    Abstract: The present invention is related to the use of spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of spiro derivatives for the modulation of CRTH2 activity.
    Type: Application
    Filed: May 23, 2006
    Publication date: December 24, 2009
    Applicant: Laboratoires Serono S.A.
    Inventors: Matthias Schwarz, Eric Sebille, Christophe Cleva, Cedric Merlot, Dennis Church, Patrick Page, Jacqueline A. Macritchie, John Frederick Atherall, Stefano Crosignani, Doris Pupowicz
  • 2,3 Substituted Pyrazine Sulfonamides as Inhibitors of CRTH2
    Publication number: 20090054447
    Abstract: The present invention is related to the use of 2,3 substituted pyrazine sulfonamides of formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of 2,3 substituted pyrazine sulfonamides for the modulation, notably the inhibition, of CRTH2 activity.
    Type: Application
    Filed: April 20, 2006
    Publication date: February 26, 2009
    Applicant: Laboratoires Serono S.A.
    Inventors: Patrick Page, Matthias Schwarz, Eric Sebille, Christophe Cleva, Cedric Merlot, Maurizio Maio